We are live on
!
Find out more
Fate Therapeutics
FATE
FATE
149 hedge funds and large institutions have $1.15B invested in Fate Therapeutics in 2019 Q3 according to their latest regulatory filings, with 27 funds opening new positions, 56 increasing their positions, 42 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
93% more first-time investments, than exits
New positions opened: 27 | Existing positions closed: 14
33% more repeat investments, than reductions
Existing positions increased: 56 | Existing positions reduced: 42
20% more funds holding in top 10
Funds holding in top 10: 5 → 6 (+1)
10% more funds holding
Funds holding: 136 → 149 (+13)
1.1% more ownership
Funds ownership: 96.88% → 97.98% (+1.1%)
11% less capital invested
Capital invested by funds: $1.28B → $1.15B (-$137M)
12% less call options, than puts
Call options by funds: $3.97M | Put options by funds: $4.51M
Holders
149
Holders Change
+13
Holders Change %
+9.56%
% of All Funds
3.27%
Holding in Top 10
6
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+20%
% of All Funds
0.13%
New
27
Increased
56
Reduced
42
Closed
14
Calls
$3.97M
Puts
$4.51M
Net Calls
-$534K
Net Calls Change
-$397K
Top Buyers
| 1 |
GH
Grosvenor Holdings
Chicago,
Illinois
|
+$43.8M |
| 2 |
Millennium Management
New York
|
+$25.5M |
| 3 |
RG
Redmile Group
San Francisco,
California
|
+$16.4M |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
+$15.3M |
| 5 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
+$14.9M |
